Op 6 mei vindt in Cambridge de New Horizons-konferentie plaats.
De konferentie wordt georganiseerd door ME Research UK én the Irish ME Trust.
|
9.10
|
Welcome and Overview of ME/CFS:
The Research Challenge.
Dr Vance Spence
(Chairman, ME Research UK, and Senior Research Fellow, University of Dundee)
|
|
|
|
|
9.30
|
Overview of intracellular immunity in ME/CFS:
State of the art and therapeutic implications.
Dr Jo Nijs
(Department of Human Physiology, Vrije Universiteit Brussel, Belgium)
|
|
|
|
|
9.50
|
Review of Clinical Aspects of ME/CFS
Prof Nancy Klimas
(University of Miami School of Medicine, Florida, USA)
|
|
|
|
|
10.20
|
Clinical Networks:
Their role in assessment, diagnosis and research.
Dr Gregor Purdie
(GP Advisor, NHS Dumfries and Galloway)
|
|
|
|
|
11.00
|
Patient-centred research in Myalgic Encephalomyelitis:
Results from a longitudinal database.
Dr Byron Hyde
(Nightingale Research Foundation, Ottawa, Canada)
|
|
|
|
|
11.20
|
New effective methods in the treatment of CFS/ME
based on immune dysfunction and the methylation cycle.
Dr. Derek Enlander
(Mount Sinai Medical School, New York and New York ME/CFS Center)
|
|
|
|
|
11.40
|
The CFS/ME Clinic in the UK:
Clinical Assessment and Service Delivery.
Dr. Gavin Spickett
(Consultant Clinical Immunologist and Clinical Champion
for Northern CFS/ME CNCC, Newcastle, UK) |
|
|
|
|
12.00
|
Clinical Studies: Autonomic, brain and muscle.
Dr Julia Newton
(Senior Lecturer, Institute of Cellular Medicine, Newcastle University)
|
|
|
|
|
1.30
|
Biomedical research in Nevada.
Dr Dan Peterson
(Whittemore Peterson Institute for Neuro-Immune Disease,
Center for Molecular Medicine, University of Nevada School of Medicine, USA)
|
|
|
|
|
2.00
|
Vascular and Inflammatory Aspects of ME/CFS.
Dr Faisel Khan
(Vascular Diseases Research Unit, University of Dundee).
|
|
|
|
|
2.30
|
Molecular studies of Chronic Fatigue Syndrome.
Dr Jonathan Kerr
(Department of Cellular & Molecular Medicine, St George's University London)
|
|
|
|
|
3.20
|
The Swedish Twin Registry:
Searching for a biomarker.
Prof Birgitta Evengard
(Dept of Infectious Diseases Umeå University, Sweden)
|
|
|
|
|
3.50
|
Q fever, Rickettsia honei and CFS.
Dr Stephen Graves
(Director Australian Rickettsial Reference Laboratory, NSW, Australia)
|
|
|
|
|
4.20
|
Discussion
Chair: Dr Vance Spence
|
|
|
|
|
5.00
|
Close
|
